Section Arrow
Quote
CPRX.NASDAQ
- Catalyst Pharmaceuticals
Quotes are at least 15-min delayed:2025/11/16 04:39 EST
Regular Hours
Last
 23.18
+0.16 (+0.70%)
Day High 
23.44 
Prev. Close
23.02 
1-M High
23.28 
Volume 
1.15M 
Bid
23.18
Ask
23.5
Day Low
22.8 
Open
22.83 
1-M Low
19.9 
Market Cap 
2.83B 
Currency USD 
P/E 13.46 
%Yield -- 
10-SMA 21.83 
20-SMA 21.43 
50-SMA 20.69 
52-W High 26.58 
52-W Low 19.05 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
1.71/2.22
Enterprise Value
2.83B
Balance Sheet
Book Value Per Share
7.49
Cash Flow
Cash Flow Yield
0.08
Income Statement
Total Revenue
491.73M
Operating Revenue Per Share
2.83
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
ASBPAspire Biopharma Holdings Inc.0.1063+0.0011+1.05%-- 
CYPHCypherpunk Technologies Inc.2.75+0.99+56.25%-- 
IVVDInvivyd2.35+0.58+32.77%-- 
APLTApplied Therapeutics0.2183-0.0517-19.15%-- 
RXRXRecursion Pharmaceuticals4.14-0.19-4.39%-- 
Quotes are at least 15-min delayed：2025/11/16 04:39 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.